KalVista Pharmaceuticals Inc
KALV
|
|
| |
|
| Trading Volume | 4,793 |
|
|
16.04 - 7.58 |
| Market Cap Full | $ 416.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 6.4% | -2.2% | 16.3% | 11.4% |
| Q2 | - | 5.6% | 14.5% | -33.2% |
| Q3 | - | 28.6% | 7% | 47.5% |
| Q4 | - | -9.4% | 36.4% | -53.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 28.7 | -13.4 | -12.2 | -4.3 | 2.1 | 2.9 | - | - | - | - | - | - |
| 2023 | |||||||||||
| 17.8 | -7.9 | 7.2 | 8.5 | 14.3 | -7.7 | 12.2 | 7.4 | -11.2 | -11.8 | -0.6 | 45.1 |
| 2022 | |||||||||||
| -4.6 | 26.7 | -7.8 | -11.3 | -32 | 10.7 | 25.5 | 33.4 | -11.9 | -65.1 | 6.3 | 25.4 |
| 2021 | |||||||||||
| -16.4 | 112.2 | -20.5 | -4.4 | 8.1 | -11.3 | -15.9 | 1.5 | -14.6 | 2.1 | -18.6 | -8.8 |
| 2020 | |||||||||||
| -16.5 | -10.1 | -43.1 | 42.6 | 3.1 | 7.6 | -18.8 | 33.3 | -5.3 | 38.7 | 8.7 | -0.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.8 | -0.9 | -0.6 | -0.5 |
| Q2 | -0.7 | -1 | -0.7 | -0.4 |
| Q3 | -0.7 | -0.9 | -0.7 | -0.6 |
| Q4 | -0.8 | -0.9 | -0.8 | -0.6 |
| A | -3.03 | -3.3 | -3.4 | -2.4 |